Dara Pincas is the Vice President, Healthcare Law Genentech, A Member of the Roche Group.
Pincas is the leader of the Healthcare Law Group which provides FDA regulatory and healthcare
law counseling to the Genentech pharmaceuticals business with revenues of approximately $25 billion and consisting of approximately 47 commercialized products and 60 pipeline molecules.
Before joining Genentech, Pincas was the Regional Legal Director for the Global Innovative Pharmaceuticals Unit at Pfizer, with responsibility for leading and managing legal matters in 32 countries located in Central & Eastern Europe and Israel.
Prior to Pfizer, Pincas completed a Clerkship in The White House, Office of Counsel to the President (William Jefferson Clinton).
Pincas is the recipient of numerous awards and recognitions throughout her career including, most recently being selected as a 2022 Wexner Heritage Fellow; recipient of the 2021 Healthcare Businesswomen’s Association Rising Star Award for Genentech; Pfizer’s Innovation Award; and the FTC’s Stephen Nye Award. Dara speaks four languages (French, Hebrew, Spanish and English).
Pincas received her J.D. from the University of Michigan Law School, where she was a Dean’s Scholar, and her B.A. from Tufts University.